Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz

Trombositoz tombosit sayısının 400.000/mm3 üzerinde olması olarak tanımlanır. İlaçlar sekonder trombositoz (ST) etyolojisinde yer almaktadır. Bu sunumda siprofloksasin tedavisi sırasında ekstrem trombositoz gelişen 23 yaşındaki bayan olguyu sunmayı amaçladık.

Anahtar Kelimeler:

Trombositoz, Siprofloksasin

PDF

___

Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
-
Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.